84 related articles for article (PubMed ID: 19467705)
21. Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.
Kayilioğlu H; Kocak U; Kan Karaer D; Percin EF; Sal E; Tekkesin F; Isik M; Oner N; Belen FB; Yilmaz Keskin E; Okur A; Albayrak M; Kaya Z; Pinarli FG; Yenicesu I; Karadeniz C; Oguz A; Gursel T
J Pediatr Hematol Oncol; 2017 Aug; 39(6):458-462. PubMed ID: 28697165
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms.
Fanta S; Niemi M; Jönsson S; Karlsson MO; Holmberg C; Neuvonen PJ; Hoppu K; Backman JT
Pharmacogenet Genomics; 2008 Feb; 18(2):77-90. PubMed ID: 18192894
[TBL] [Abstract][Full Text] [Related]
23. Vincristine pharmacokinetics in children with Down syndrome.
Lönnerholm G; Frost BM; Söderhäll S; de Graaf SS
Pediatr Blood Cancer; 2009 Jan; 52(1):123-5. PubMed ID: 18615507
[TBL] [Abstract][Full Text] [Related]
24. The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients.
Tirelli S; Ferraresso M; Ghio L; Meregalli E; Martina V; Belingheri M; Mattiello C; Torresani E; Edefonti A
Med Sci Monit; 2008 May; 14(5):CR251-254. PubMed ID: 18443548
[TBL] [Abstract][Full Text] [Related]
25. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia.
Urayama KY; Wiencke JK; Buffler PA; Chokkalingam AP; Metayer C; Wiemels JL
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1172-7. PubMed ID: 17548681
[TBL] [Abstract][Full Text] [Related]
26. [Study on polymorphisms of CYP3A5 gene and their clinical role].
Wang HP; Xie JJ; Zhang ZY; Ying Y; Zhu ZG; Mao P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):423-6. PubMed ID: 16086282
[TBL] [Abstract][Full Text] [Related]
27. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.
Kim KA; Park PW; Lee OJ; Choi SH; Min BH; Shin KH; Chun BG; Shin JG; Park JY
Clin Pharmacol Ther; 2006 Dec; 80(6):646-56. PubMed ID: 17178265
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
[TBL] [Abstract][Full Text] [Related]
29. [Gene polymorphisms of CYP3A5 and MDR-1 in Hans renal transplant recipients in Hunan Province].
Shao M; Ye Q; She X; Liu H; Ye S; Niu Y; Ming Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):824-9. PubMed ID: 23981990
[TBL] [Abstract][Full Text] [Related]
30. No association between single nucleotide polymorphisms and the development of nephrotoxicity after orthotopic heart transplantation.
Klauke B; Wirth A; Zittermann A; Bohms B; Tenderich G; Körfer R; Milting H
J Heart Lung Transplant; 2008 Jul; 27(7):741-5. PubMed ID: 18582803
[TBL] [Abstract][Full Text] [Related]
31. A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?
Le Guellec C; Benz-de Bretagne I; Jonville-Bera AP; Tarfaoui N; Andres CR; Gendrot C; Jourdain A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e341-3. PubMed ID: 22627576
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous detection of CYP3A5 and MDR1 polymorphisms based on the SNaPshot assay.
Li L; Li CJ; Zhang YJ; Zheng L; Jiang HX; Si-Tu B
Clin Biochem; 2011 Apr; 44(5-6):418-22. PubMed ID: 21237140
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics of pediatric acute lymphoblastic leukemia.
Meeker ND; Yang JJ; Schiffman JD
Expert Opin Pharmacother; 2010 Jul; 11(10):1621-32. PubMed ID: 20429672
[TBL] [Abstract][Full Text] [Related]
34. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.
Ceppi F; Langlois-Pelletier C; Gagné V; Rousseau J; Ciolino C; De Lorenzo S; Kevin KM; Cijov D; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Pharmacogenomics; 2014 Jun; 15(8):1105-16. PubMed ID: 25084203
[TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases.
Guilhaumou R; Simon N; Quaranta S; Verschuur A; Lacarelle B; Andre N; Solas C
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1191-8. PubMed ID: 21404110
[TBL] [Abstract][Full Text] [Related]
37. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia.
Kamdem LK; Hamilton L; Cheng C; Liu W; Yang W; Johnson JA; Pui CH; Relling MV
Pharmacogenet Genomics; 2008 Jun; 18(6):507-14. PubMed ID: 18496130
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study.
Zgheib NK; Ghanem KM; Tamim H; Aridi C; Shahine R; Tarek N; Saab R; Abboud MR; El-Solh H; Muwakkit SA
Pharmacogenet Genomics; 2018 Aug; 28(8):189-195. PubMed ID: 30119132
[TBL] [Abstract][Full Text] [Related]
39. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
Kishi S; Yang W; Boureau B; Morand S; Das S; Chen P; Cook EH; Rosner GL; Schuetz E; Pui CH; Relling MV
Blood; 2004 Jan; 103(1):67-72. PubMed ID: 12969965
[TBL] [Abstract][Full Text] [Related]
40. Motor performance of children during treatment for acute lymphoblastic leukemia.
Reinders-Messelink H; Schoemaker M; Snijders T; Göeken L; van Den Briel M; Bökkerink J; Kamps W
Med Pediatr Oncol; 1999 Dec; 33(6):545-50. PubMed ID: 10573577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
